Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Ana Rita Ferreira Leite

    Autor

  • João Sérgio De Lima Soares Neves

    Autor

Participantes de fora da FMUP

  • Papazoglou, Andreas S.
  • Moysidis, V, Dimitrios
  • Anastasiou, Vasileios
  • Daios, Stylianos
  • Borges-Canha, Marta
  • Giannopoulos, Georgios
  • Ziakas, Antonios
  • Giannakoulas, George

Unidades de investigação

Abstract

Context Prolactin (PRL) is a highly versatile, multifunctional hormone synthesized and secreted by lactotroph cells of the anterior pituitary. Its metabolic role has been extensively studied even in normoprolactinemic populations. Recently, a wealth of observational data have outlined the potential prognostic value of PRL in various clinical settings.Objective This systematic review aims to systematically evaluate and quantitatively synthesize the association between serum PRL levels and risk of mortality in adults without prolactinoma.Methods A systematic literature search was conducted up to June 10, 2023, to identify studies reporting the association of serum PRL levels with clinical outcomes of adults without prolactinoma. A random-effects meta-analysis was conducted to quantify the adjusted hazard ratios [(a)HRs] for all-cause and cardiovascular death (CVD) during follow-up.Results Twenty-eight studies were deemed eligible reporting the outcomes of adults without prolactinoma, in whom serum PRL levels were measured for risk-stratification. Fourteen studies reported appropriate data for meta-analysis encompassing a total of 23 596 individuals. Each unit of PRL increase was independently associated with increased risk of all-cause (pooled aHR = 1.17 [1.08-1.27]; I2 = 48%) and CV mortality (pooled aHR = 1.54 [1.14-2.09]; I2 = 89%). Individuals belonging to the highest PRL category had significantly higher risk for all-cause (pooled aHR = 1.81 [1.43-2.30]; I2 = 65%) and CV (pooled aHR = 1.59 [1.04-2.42]; I2 = 82%) mortality compared to their lowest-PRL category counterparts. The association between PRL levels and in-hospital death did not reach statistical significance.Conclusion PRL levels seem to be an independent predictor for mortality. Further validation is warranted before its role as a risk-stratification tool can be delineated in clinical practice.

Dados da publicação

ISSN/ISSNe:
0021-972X, 1945-7197

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM  Endocrine Society

Tipo:
Article
Páginas:
1652-1664
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 4

Citações Recebidas na Scopus: 4

Documentos

  • Não há documentos

Filiações mostrar / ocultar

Keywords

  • prolactin; biomarker; cardiovascular risk; cardiovascular death; risk stratification

Proyectos asociados

Predictors of readmission and mortality in patients with decompensated heart failure according to glycaemic status

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Glycaemic status) . 2023

Association of Glycemic Variability and Time in Range with Lipid Profile in Type 1 Diabetes

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Glycemic Variability) . 2023

Time in Range and Complications of Diabetes: a Cross-Sectional Analysis of patients with Type 1 Diabetes

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Type 1 Diabetes) . 2023

Evaluation of thyroid function in patients hospitalized for acute heart failure

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Heart failure) . 2021

Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2021

Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2022

Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Hydrodistension ) . 2022

Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação